Skip to NavigationSkip to content

Pharmafile - Manufacturing and Production

Researchers successfully minimise diabetes drug side-effects in animal models
Researchers at the University of Pennsylvania and Syracuse University have modified a key ingredient of current diabetes drugs to produce a...
Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?
Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary endpoint...
J&J stops Invokana trial early after success in kidney disease and type 2 diabetes
Johnson & Johnson and research arm Janssen have taken the decision to terminate a Phase 3 trial evaluating the efficacy of its SGLT2 inhibitor...
FDA cautions consumers on fake warning letter scam
The FDA has warned that criminals have been targeting customers who bought medicines online or over the phone with “official-looking, but fake,...
>> More Manufacturing and Production News Stories

Features

Recruitment and retention: How can we do better?

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt Fellows...

>> More Features

Appointments

Silence Therapeutics appoints ex-Akari CEO in top position

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head the...

For more appointments click here

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches